12 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
informed through committee reports about such risks.
Board Diversity
Our nominating and corporate governance committee is responsible for reviewing … as a whole and its individual members. Although our board of directors does not have a formal written diversity policy with respect to the evaluation
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
will be regularly informed through committee reports about such risks.
Board Diversity
Our nominating and corporate governance committee will be responsible … of directors as a whole and its individual members. Although our board of directors does not have a formal written diversity policy with respect
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
, our entire board of directors will be regularly informed through committee reports about such risks.
Board Diversity
Our nominating and corporate … diversity policy with respect to the evaluation of director candidates, in its evaluation of director candidates, our nominating and corporate
S-1
EX-99.4
0dcgahfh0 682sz7gzn
29 Jun 23
IPO registration
4:39pm
S-1
eztqptr
29 Jun 23
IPO registration
4:39pm
DRS/A
vmj2ut
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
aqgakd3z2
2 May 23
Draft registration statement (amended)
12:00am
DRS
op20ej9
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next